Home > > > Report Detail

Global (United States, European Union and China) Remicade (infliximab) Drug Market Research Report 2019-2025

Publisher Name :
Date: 29-Jul-2019
No. of pages: 111
Inquire Before Buying

Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-a) and is used to treat autoimmune diseases.

In 2019, the market size of Remicade (infliximab) Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Remicade (infliximab) Drug.

This report studies the global market size of Remicade (infliximab) Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Remicade (infliximab) Drug production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Janssen

- Hospira

- Celltrion Healthcare

- Epirus Biopharmaceuticals

- Samsung Bioepsis

- ...

Market Segment by Product Type

- Brands Drugs

- Generic Drugs

Market Segment by Application

- Crohn's Disease

- Pediatric Crohn's Disease

- Ulcerative Colitis

- Pediatric Ulcerative Colitis

- Other

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Remicade (infliximab) Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Remicade (infliximab) Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Remicade (infliximab) Drug are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Remicade (infliximab) Drug Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Remicade (infliximab) Drug Market Size Growth Rate by Type (2019-2025)
1.3.2 Brands Drugs
1.3.3 Generic Drugs
1.4 Market Segment by Application
1.4.1 Global Remicade (infliximab) Drug Market Share by Application (2019-2025)
1.4.2 Crohn's Disease
1.4.3 Pediatric Crohn's Disease
1.4.4 Ulcerative Colitis
1.4.5 Pediatric Ulcerative Colitis
1.4.6 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Remicade (infliximab) Drug Production Value 2014-2025
2.1.2 Global Remicade (infliximab) Drug Production 2014-2025
2.1.3 Global Remicade (infliximab) Drug Capacity 2014-2025
2.1.4 Global Remicade (infliximab) Drug Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Remicade (infliximab) Drug Market Size CAGR of Key Regions
2.2.2 Global Remicade (infliximab) Drug Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Remicade (infliximab) Drug Capacity by Manufacturers
3.1.2 Global Remicade (infliximab) Drug Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Remicade (infliximab) Drug Revenue by Manufacturers (2014-2019)
3.2.2 Remicade (infliximab) Drug Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Remicade (infliximab) Drug Market Concentration Ratio (CR5 and HHI)
3.3 Remicade (infliximab) Drug Price by Manufacturers
3.4 Key Manufacturers Remicade (infliximab) Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Remicade (infliximab) Drug Market
3.6 Key Manufacturers Remicade (infliximab) Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Brands Drugs Production and Production Value (2014-2019)
4.1.2 Generic Drugs Production and Production Value (2014-2019)
4.2 Global Remicade (infliximab) Drug Production Market Share by Type
4.3 Global Remicade (infliximab) Drug Production Value Market Share by Type
4.4 Remicade (infliximab) Drug Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Remicade (infliximab) Drug Consumption by Application
6 Production by Regions
6.1 Global Remicade (infliximab) Drug Production (History Data) by Regions 2014-2019
6.2 Global Remicade (infliximab) Drug Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Remicade (infliximab) Drug Production Growth Rate 2014-2019
6.3.2 United States Remicade (infliximab) Drug Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Remicade (infliximab) Drug Import & Export
6.4 European Union
6.4.1 European Union Remicade (infliximab) Drug Production Growth Rate 2014-2019
6.4.2 European Union Remicade (infliximab) Drug Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Remicade (infliximab) Drug Import & Export
6.5 China
6.5.1 China Remicade (infliximab) Drug Production Growth Rate 2014-2019
6.5.2 China Remicade (infliximab) Drug Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Remicade (infliximab) Drug Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Remicade (infliximab) Drug Consumption by Regions
7.1 Global Remicade (infliximab) Drug Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Remicade (infliximab) Drug Consumption by Type
7.2.2 United States Remicade (infliximab) Drug Consumption by Application
7.3 European Union
7.3.1 European Union Remicade (infliximab) Drug Consumption by Type
7.3.2 European Union Remicade (infliximab) Drug Consumption by Application
7.4 China
7.4.1 China Remicade (infliximab) Drug Consumption by Type
7.4.2 China Remicade (infliximab) Drug Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Remicade (infliximab) Drug Consumption by Type
7.5.2 Rest of World Remicade (infliximab) Drug Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Janssen
8.1.1 Janssen Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Remicade (infliximab) Drug
8.1.4 Remicade (infliximab) Drug Product Introduction
8.1.5 Janssen Recent Development
8.2 Hospira
8.2.1 Hospira Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Remicade (infliximab) Drug
8.2.4 Remicade (infliximab) Drug Product Introduction
8.2.5 Hospira Recent Development
8.3 Celltrion Healthcare
8.3.1 Celltrion Healthcare Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Remicade (infliximab) Drug
8.3.4 Remicade (infliximab) Drug Product Introduction
8.3.5 Celltrion Healthcare Recent Development
8.4 Epirus Biopharmaceuticals
8.4.1 Epirus Biopharmaceuticals Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Remicade (infliximab) Drug
8.4.4 Remicade (infliximab) Drug Product Introduction
8.4.5 Epirus Biopharmaceuticals Recent Development
8.5 Samsung Bioepsis
8.5.1 Samsung Bioepsis Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Remicade (infliximab) Drug
8.5.4 Remicade (infliximab) Drug Product Introduction
8.5.5 Samsung Bioepsis Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Remicade (infliximab) Drug Capacity, Production Forecast 2019-2025
9.1.2 Global Remicade (infliximab) Drug Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Remicade (infliximab) Drug Production and Value Forecast by Regions 2019-2025
9.2.2 Global Remicade (infliximab) Drug Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Remicade (infliximab) Drug Production Forecast by Type
9.7.2 Global Remicade (infliximab) Drug Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Remicade (infliximab) Drug Sales Channels
10.2.2 Remicade (infliximab) Drug Distributors
10.3 Remicade (infliximab) Drug Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables and Figures
Figure Remicade (infliximab) Drug Product Picture
Table Remicade (infliximab) Drug Key Market Segments
Table Major Manufacturers Remicade (infliximab) Drug Covered in This Report
Table Global Remicade (infliximab) Drug Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Remicade (infliximab) Drug Sales Market Shar by Type 2014-2025
Figure Brands Drugs Figures
Table Major Manufacturers of Brands Drugs
Figure Generic Drugs Figures
Table Major Manufacturers of Generic Drugs
Table Global Remicade (infliximab) Drug Market Share by Application 2019-2025 (K Units)
Figure Crohn's Disease Use Case
Figure Pediatric Crohn's Disease Use Case
Figure Ulcerative Colitis Use Case
Figure Pediatric Ulcerative Colitis Use Case
Figure Other Use Case
Figure Remicade (infliximab) Drug Report Years Considered
Figure Global Remicade (infliximab) Drug Production Value Growth Rate 2014-2025 (Million US$)
Figure Global Remicade (infliximab) Drug Production 2014-2025 (K Units)
Figure Global Remicade (infliximab) Drug Capacity 2014-2025 (K Units)
Table Key Manufacturers Remicade (infliximab) Drug Capacity (K Units)
Figure Global Remicade (infliximab) Drug Price 2014-2025 (USD/Unit)
Table Global Remicade (infliximab) Drug Market Size of Key Regions (Million USD) & (K Units)
Table Global Remicade (infliximab) Drug Growth Rate of Key Regions 2019-2025 (Million USD)
Table Global Remicade (infliximab) Drug Market Share for of Regions 2019-2025 (K Units)
Table Market Top Trends
Table Global Remicade (infliximab) Drug Capacity by Manufacturers (2014-2019) (K Units)
Table Global Remicade (infliximab) Drug Capacity Market Share by Manufacturers (2014-2019)
Table Global Remicade (infliximab) Drug Production by Manufacturers (2014-2019) (K Units)
Table Global Remicade (infliximab) Drug Production Share by Manufacturers (2014-2019)
Figure Global Remicade (infliximab) Drug Production Share by Manufacturers in 2018
Table Remicade (infliximab) Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Remicade (infliximab) Drug Revenue Share by Manufacturers (2014-2019)
Figure Remicade (infliximab) Drug Value Share by Manufacturers in 2018
Table Global Remicade (infliximab) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Remicade (infliximab) Drug Price by Manufacturers 2014-2019 (USD/Unit)
Table Key Manufacturers Remicade (infliximab) Drug Plants/Factories Distribution
Table Key Manufacturers Remicade (infliximab) Drug Area Served
Table Date of Key Manufacturers Enter into Remicade (infliximab) Drug Market
Table Key Manufacturers Remicade (infliximab) Drug Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Brands Drugs Production and Production Value (2014-2019) (K Units) & (Million US$)
Table Global Generic Drugs Production and Production Value (2014-2019) (K Units) & (Million US$)
Table Global Remicade (infliximab) Drug Production by Type (2014-2019) (K Units)
Table Global Remicade (infliximab) Drug Production Share by Type (2014-2019)
Figure Global Remicade (infliximab) Drug Production Market Share by Type (2014-2019)
Figure Global Remicade (infliximab) Drug Production Market Share by Type in 2018
Table Global Remicade (infliximab) Drug Production Value by Type (2014-2019) (Million US$)
Table Global Remicade (infliximab) Drug Production Value Share by Type (2014-2019)
Figure Global Remicade (infliximab) Drug Production Value Market Share by Type (2014-2019)
Figure Global Remicade (infliximab) Drug Production Value Market Share by Type in 2018
Table Remicade (infliximab) Drug Ex-factory Price by Type 2014-2019 (USD/Unit)
Table Global Remicade (infliximab) Drug Consumption by Application (2014-2019) (K Units)
Table Global Remicade (infliximab) Drug Consumption Share by Application (2014-2019)
Figure Global Consumption Remicade (infliximab) Drug Market Share by Application (2014-2019)
Table Global Remicade (infliximab) Drug Production by Regions 2014-2019 (K Units)
Table Global Remicade (infliximab) Drug Production Market Share by Regions 2014-2019
Figure Global Remicade (infliximab) Drug Production Market Share by Regions 2014-2019
Figure Global Remicade (infliximab) Drug Production Market Share by Regions in 2018
Table Global Remicade (infliximab) Drug Production Value by Regions 2014-2019 (Million USD)
Table Global Remicade (infliximab) Drug Production Value Market Share by Regions 2014-2019
Figure Global Remicade (infliximab) Drug Production Value Market Share by Regions 2014-2019
Figure Global Remicade (infliximab) Drug Production Value Market Share by Regions in 2018
Table United States Remicade (infliximab) Drug Production and Value 2014-2019 (K Units) & (Million USD)
Figure United States Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure United States Remicade (infliximab) Drug Production Value Growth Rate 2014-2019 (Million USD)
Table United States Remicade (infliximab) Drug Import & Export (K Units)
Table European Union Remicade (infliximab) Drug Production and Value 2014-2019 (K Units) & (Million USD)
Figure European Union Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure European Union Remicade (infliximab) Drug Production Value Growth Rate 2014-2019 (Million USD)
Table European Union Remicade (infliximab) Drug Import & Export (K Units)
Table China Remicade (infliximab) Drug Production and Value 2014-2019 (K Units) & (Million USD)
Figure China Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure China Remicade (infliximab) Drug Production Value Growth Rate 2014-2019 (Million USD)
Table China Remicade (infliximab) Drug Import & Export (K Units)
Figure Japan Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure Japan Remicade (infliximab) Drug Production Value Growth Rate 2014-2019 (Million USD)
Figure Korea Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure Korea Remicade (infliximab) Drug Production Value Growth Rate 2014-2019 (Million USD)
Figure India Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure India Remicade (infliximab) Drug Production Value Growth Rate 2014-2019 (Million USD)
Figure Southeast Asia Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Remicade (infliximab) Drug Production Value Growth Rate 2014-2019 (Million USD)
Table Global Remicade (infliximab) Drug Consumption by Regions 2014-2019 (K Units)
Table Global Remicade (infliximab) Drug Consumption Market Share by Regions 2014-2019
Figure Global Remicade (infliximab) Drug Consumption Market Share by Regions 2014-2019
Figure Global Remicade (infliximab) Drug Consumption Market Share by Regions in 2018
Figure United States Remicade (infliximab) Drug Consumption Growth Rate (2014-2019) (K Units)
Table United States Remicade (infliximab) Drug Consumption by Type (2014-2019) (K Units)
Figure United States Remicade (infliximab) Drug Consumption Market Share by Type in 2019
Table United States Remicade (infliximab) Drug Consumption by Application (2014-2019) (K Units)
Figure United States Remicade (infliximab) Drug Consumption Market Share by Application in 2019
Figure European Union Remicade (infliximab) Drug Consumption Growth Rate (2014-2019) (K Units)
Table European Union Remicade (infliximab) Drug Consumption by Type (2014-2019) (K Units)
Figure European Union Remicade (infliximab) Drug Consumption Market Share by Type in 2019
Table European Union Remicade (infliximab) Drug Consumption by Application (2014-2019) (K Units)
Figure European Union Remicade (infliximab) Drug Consumption Market Share by Application in 2019
Figure China Remicade (infliximab) Drug Consumption Growth Rate (2014-2019) (K Units)
Table China Remicade (infliximab) Drug Consumption by Type (2014-2019) (K Units)
Figure China Remicade (infliximab) Drug Consumption Market Share by Type in 2019
Table China Remicade (infliximab) Drug Consumption by Application (2014-2019) (K Units)
Figure China Remicade (infliximab) Drug Consumption Market Share by Application in 2019
Figure Rest of World Remicade (infliximab) Drug Consumption Growth Rate (2014-2019) (K Units)
Table Rest of World Remicade (infliximab) Drug Consumption by Type (2014-2019) (K Units)
Figure Rest of World Remicade (infliximab) Drug Consumption Market Share by Type in 2019
Table Rest of World Remicade (infliximab) Drug Consumption by Application (2014-2019) (K Units)
Figure Rest of World Remicade (infliximab) Drug Consumption Market Share by Application in 2019
Figure Japan Remicade (infliximab) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Korea Remicade (infliximab) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure India Remicade (infliximab) Drug Consumption Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Remicade (infliximab) Drug Consumption Growth Rate (2014-2019) (K Units)
Table Janssen Company Details
Table Janssen Description and Business Overview
Table Janssen Remicade (infliximab) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Janssen Remicade (infliximab) Drug Production Growth Rate (2014-2019)
Table Janssen Remicade (infliximab) Drug Production Market Share in Global Market
Table Janssen Recent Development
Table Hospira Company Details
Table Hospira Description and Business Overview
Table Hospira Remicade (infliximab) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Hospira Remicade (infliximab) Drug Production Growth Rate (2014-2019)
Table Hospira Remicade (infliximab) Drug Production Market Share in Global Market
Table Hospira Recent Development
Table Celltrion Healthcare Company Details
Table Celltrion Healthcare Description and Business Overview
Table Celltrion Healthcare Remicade (infliximab) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Celltrion Healthcare Remicade (infliximab) Drug Production Growth Rate (2014-2019)
Table Celltrion Healthcare Remicade (infliximab) Drug Production Market Share in Global Market
Table Celltrion Healthcare Recent Development
Table Epirus Biopharmaceuticals Company Details
Table Epirus Biopharmaceuticals Description and Business Overview
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Production Growth Rate (2014-2019)
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Production Market Share in Global Market
Table Epirus Biopharmaceuticals Recent Development
Table Samsung Bioepsis Company Details
Table Samsung Bioepsis Description and Business Overview
Table Samsung Bioepsis Remicade (infliximab) Drug Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Samsung Bioepsis Remicade (infliximab) Drug Production Growth Rate (2014-2019)
Table Samsung Bioepsis Remicade (infliximab) Drug Production Market Share in Global Market
Table Samsung Bioepsis Recent Development
Table Global Remicade (infliximab) Drug Capacity, Production Forecast 2019-2025 (K Units)
Figure Global Remicade (infliximab) Drug Capacity Forecast 2019-2025 (K Units)
Figure Global Remicade (infliximab) Drug Production Forecast 2019-2025 (K Units)
Figure Global Remicade (infliximab) Drug Production Value Forecast 2019-2025 (Million US$)
Table Global Remicade (infliximab) Drug Production Value Forecast 2019-2025 (Million US$)
Table Global Remicade (infliximab) Drug Production Forecast by Regions 2019-2025 (K Units)
Table Global Remicade (infliximab) Drug Production Market Share Forecast by Regions 2019-2025
Table Global Remicade (infliximab) Drug Production Value Forecast by Regions 2019-2025 (Million US$)
Table Global Remicade (infliximab) Drug Consumption Forecast by Regions 2019-2025 (K Units)
Table Global Remicade (infliximab) Drug Consumption Market Share Forecast by Regions 2019-2025
Table United States Remicade (infliximab) Drug Production and Production Value Forecast 2019-2025 (K Units) & (Million US$)
Figure United States Remicade (infliximab) Drug Production Growth Forecast 2019-2025 (K Units)
Table United States Remicade (infliximab) Drug Production Value Forecast 2019-2025 (Million US$)
Figure United States Remicade (infliximab) Drug Consumption Forecast 2019-2025 (K Units)
Table European Union Remicade (infliximab) Drug Production and Production Value Forecast 2019-2025 (K Units) & (Million US$)
Figure European Union Remicade (infliximab) Drug Production Growth Forecast 2019-2025 (K Units)
Table European Union Remicade (infliximab) Drug Production Value Forecast 2019-2025 (Million US$)
Figure European Union Remicade (infliximab) Drug Consumption Forecast 2019-2025 (K Units)
Table China Remicade (infliximab) Drug Production and Production Value Forecast 2019-2025 (K Units) & (Million US$)
Figure China Remicade (infliximab) Drug Production Growth Forecast 2019-2025 (K Units)
Table China Remicade (infliximab) Drug Production Value Forecast 2019-2025 (Million US$)
Figure China Remicade (infliximab) Drug Consumption Forecast 2019-2025 (K Units)
Figure Japan Remicade (infliximab) Drug Production Growth Forecast 2019-2025 (K Units)
Figure Japan Remicade (infliximab) Drug Consumption Forecast 2019-2025 (K Units)
Figure Korea Remicade (infliximab) Drug Production Growth Forecast 2019-2025 (K Units)
Figure Korea Remicade (infliximab) Drug Consumption Forecast 2019-2025 (K Units)
Figure India Remicade (infliximab) Drug Production Growth Forecast 2019-2025 (K Units)
Figure India Remicade (infliximab) Drug Consumption Forecast 2019-2025 (K Units)
Figure Southeast Asia Remicade (infliximab) Drug Production Growth Forecast 2019-2025 (K Units)
Figure Southeast Asia Remicade (infliximab) Drug Consumption Forecast 2019-2025 (K Units)
Table Global Remicade (infliximab) Drug Production Forecast by Type 2019-2025 (K Units)
Figure Global Remicade (infliximab) Drug Production Forecast by Type 2019-2025 (K Units)
Figure Global Remicade (infliximab) Drug Production Market Share Forecast by Type 2019-2025
Table Global Remicade (infliximab) Drug Production Value Forecast by Type 2019-2025 (Million US$)
Figure Global Remicade (infliximab) Drug Production Value Forecast by Type 2019-2025 (Million US$)
Figure Global Remicade (infliximab) Drug Production Value Market Share Forecast by Type 2019-2025
Table Global Remicade (infliximab) Drug Consumption Forecast by Application 2019-2025 (K Units)
Figure Global Remicade (infliximab) Drug Consumption Forecast by Application 2019-2025 (K Units)
Figure Global Remicade (infliximab) Drug Consumption Market Share Forecast by Application 2019-2025
Figure Remicade (infliximab) Drug Value Chain
Table Remicade (infliximab) Drug Distributors List
Table Remicade (infliximab) Drug Customers List
Table Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs